Spray-dried microparticulate systems containing acetaminophen

被引:3
作者
Billon, A [1 ]
Bataille, B [1 ]
Delalonde, M [1 ]
Jacob, N [1 ]
机构
[1] Univ Montpellier 1, UFR Sci Pharmaceut & Biol, Lab Pharm Galen Pharmacotech & Biopharm, EA 3008 Genie Procedes & Sci Aliments, F-34060 Montpellier 2, France
关键词
controlled release; matrix system; spray-drying; acetaminophen; cellulosic derivatives; microparticle;
D O I
10.1080/02652040110065459
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
The present work investigates the preparation and the release of acetaminophen from spray-dried microparticles. Two cellulose derivatives were tested as sustaining agents: microcrystalline cellulose (MCC) and sodium carboxymethylcellulose (NaCMC). In-vitro dissolution studies were carried out in dissolution media of different pH. With MCC, the adsorption of acetaminophen on the surface or in the pores of the polymer does not allow a significant sustained release of the drug, which completely dissolves in 1 h. Conversely, the use of NaCMC retards the release of acetaminophen over a period of 6-8 h. The drug release depends on the plasticizer used and on the pH of the dissolution medium, and the mechanism consists essentially in the diffusion of the drug through the swollen polymeric matrix. The pH dependence observed can be correlated with a lower hydrophylicity of the polymer in acidic medium, which retards gel formation.
引用
收藏
页码:165 / 172
页数:8
相关论文
共 12 条
[1]  
ALDERMAN D A, 1984, International Journal of Pharmaceutical Technology and Product Manufacture, V5, P1
[2]  
BENTEJAC R, 1992, STP PHARM PRATIQUES, V2, P500
[3]   Development of spray-dried acetaminophen microparticles using experimental designs [J].
Billon, A ;
Bataille, B ;
Cassanas, G ;
Jacob, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 203 (1-2) :159-168
[4]   Effects of cellulose derivatives and additives in the spray-drying preparation of acetaminophen delivery systems [J].
Billon, A ;
Petit, M ;
Doko, MB ;
Bataille, B ;
Jacob, M .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (11) :1149-1156
[5]  
BORAIE NA, 1990, STP PHARM, V6, P6
[6]  
Brossard C., 1990, STP PHARM, V6, P728
[7]  
*EUR PHARM, 1998, ESS DISS FORM OR SOL
[8]  
GAUDY D, 1989, STP PHARM, V5, P750
[9]  
GIBASSIER D, 1982, LAB PHARM PROBL TECH, V30, P249